Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

Nurse Practitioner December 2009 Gujral & Collantes	Understanding Viral Hepatitis: A guide for primary care Recent advancements in the field of genomics and proteomics technology have given researchers and clinicians more insight on disease pathogenesis and helped create more tailored approaches to the treatment of these conditions.
American Family Physician December 15, 2003 Monika N. Daftary	Adefovir (Hepsera) for Chronic Hepatitis B Infection Adefovir offers an effective first-line alternative for the treatment of chronic hepatitis B. It also may prove to be useful in patients who have failed therapy with lamivudine as well as in patients who have difficulty tolerating interferon alfa-2b.
American Family Physician February 15, 2003	Antiviral Drugs in the Immunocompetent Host: Part I. Treatment of Hepatitis, Cytomegalovirus, and Herpes Infections
American Family Physician January 1, 2004	Hepatitis B Infection What is hepatitis B virus?... How can I tell if I have HBV infection?... What happens after HBV infection?... What health problems can chronic HBV infection cause?... How can I protect my liver if I have chronic HBV infection?... How can HBV infection be prevented?... etc.
American Family Physician June 15, 2006 Brundage & Fitzpatrick	Hepatitis A The introduction of hepatitis A vaccines in 1995 led to a drop in the number of reported cases of hepatitis A and a shift to a higher percentage of cases occurring in older age groups. The hepatitis A virus survives for extended periods in the environment.
American Family Physician March 15, 2004	Management of Hepatitis C: Evaluating Suitability for Drug Therapy Chronic hepatitis C virus infection is a common and serious disease. Although an estimated 2.7 million persons in the United States have this disease, most have not yet been diagnosed.
Nursing December 2008 Susan Simmons Holcomb	Caring for a patient with chronic hepatitis C Teach your patient about improved treatments that can help him deal with this potentially deadly infection.
American Family Physician January 15, 2006 Ann M. Khalsa	Preventive Counseling, Screening, and Therapy for the Patient with Newly Diagnosed HIV Infection The epidemic of HIV continues, and the infection is converting into a treatable chronic disease; therefore, it is increasingly important for family physicians to be current with and comfortable in providing basic care to patients infected with HIV.
American Family Physician November 1, 2001 Thomas R. Riley	Preventive Strategies in Chronic Liver Disease Chronic liver disease is the 10th leading cause of death in the United States. Preventive care can significantly reduce the progression of liver disease. Part I: Alcohol, Vaccines, Toxic Medications and Supplements, Diet and Exercise...
American Family Physician August 15, 2005 Ward & Kugelmas	Using Pegylated Interferon and Ribavirin to Treat Patients with Chronic Hepatitis C New treatment regimens and advances in the management of side effects and toxicities have expanded the pool of patients who can be treated with pegylated interferon and ribavirin.
Nursing May 2009 Davenport & Myers	How to Protect Yourself After Body Fluid Exposure Here's how you can minimize the risk of disease transmission if you or a coworker is accidentally exposed to blood or another potentially infectious body fluid.
American Family Physician September 1, 2006 Heidelbaugh & Bruderly	Cirrhosis and Chronic Liver Failure: Part I. Diagnosis and Evaluation Part I of a two-part on how to diagnose and determine treatment for cirrhosis and chronic liver failure.
American Journal of Nursing March 2010 Bradley-Springer et al.	Every Nurse Is an HIV Nurse The evolution of HIV infection into a chronic disease has implications across all clinical care settings. Every nurse should be knowledgeable about the disease in order to provide high-quality care to people with or at risk for HIV.
Nursing January 2011 Carl A. Kirton	HIV: The Changing Epidemic Since its emergence in the early 1980s, HIV infection in the United States has evolved from an acute debilitating condition to a chronic, treatable illness.
American Family Physician May 15, 2002 Alex H. Krist & Amy Crawford-Faucher	Management of Newborns Exposed to Maternal HIV Infection The management of infants whose mothers are infected with the human immunodeficiency virus involves minimizing the risk of vertical transmission of HIV, recognizing neonatal HIV infection early, preventing opportunistic infections, and addressing psychosocial issues...
American Family Physician July 15, 2003 Sur et al.	Vaccinations in Pregnancy Routine vaccines that generally are safe to administer during pregnancy include diphtheria, tetanus, influenza, and hepatitis B. Other vaccines, such as meningococcal and rabies, may be considered.
American Family Physician February 1, 2007 Servey et al.	Clinical Presentations of Parvovirus B19 Infection Generally, erythema infectiosum is self-limited and does not require treatment. Patients with arthralgia may require nonsteroidal anti-inflammatory drug treatment.
American Family Physician October 15, 2005 John G. Beauman	Genital Herpes: A Review Genital herpes simplex virus infection is a recurrent, lifelong disease with no cure. The strongest predictor for infection is a person's number of lifetime sex partners. Counseling patients about the risk of transmission is crucial and helps prevent the spread of disease and neonatal complications.
American Family Physician April 15, 2005 Kirkham, Harris & Grzybowski	Evidence-Based Prenatal Care: Part II. Third-Trimester Care and Prevention of Infectious Diseases Recommendations for care, disease screening, labor induction and vaccinations for patients during late pregnancy.
American Family Physician January 15, 2004 Roche & Kobos	Jaundice in the Adult Patient Jaundice in an adult patient can be caused by a wide variety of benign or life-threatening disorders. Organizing the differential diagnosis by prehepatic, intrahepatic, and posthepatic causes may help make the work-up more manageable.
Nursing June 2010 Daniel A. Hussar	New drugs 2010, part 2 In this article, you'll learn about 14 recently marketed new drugs.
American Family Physician March 15, 2005 Paul T. Giboney	Mildly Elevated Liver Transaminase Levels in the Asymptomatic Patient Mild elevations in liver chemistry tests can reveal serious underlying conditions or have transient and benign etiologies. If elevations persist after an appropriate period of observation, further testing may include ultrasonography and other serum studies.
Nursing June 2011 Daniel A. Hussar	New Drugs 2011: Part 2 In this article, you'll learn about seven recently approved drugs, including: fingolimod hydrochloride, an oral drug indicated to treat patients with relapsing forms of multiple sclerosis.
Nursing February 2010 Daniel A. Hussar	New Drugs 2010, PART 1 In this article, you'll learn about 16 new drugs.
American Family Physician July 1, 2004 Lo Re & Gluckman	Travel Immunizations The approach to vaccine recommendations should be based on a thorough assessment of the risks for travel-related diseases, the time available before trip departure, and current knowledge of the epidemiology of vaccine-preventable diseases.
American Family Physician May 1, 2004 Daniel Knight	Health Care Screening for Men Who Have Sex with Men Recommendations on health care screenings for men who have sex with men, who are at increased risk for STDs such as HIV infection, anal cancer, and psychologic and behavioral disorders.
American Family Physician November 15, 2001 Thomas R. Riley	Preventive Strategies in Chronic Liver Disease: Part II. Cirrhosis Cirrhosis is a diffuse process characterized by fibrosis and the conversion of normal liver architecture into structurally abnormal nodules. Strategies have been established to prevent complications in patients with cirrhosis...
The Motley Fool August 10, 2010 Ryan McBride	Vertex's Telaprevir Clears Hurdle, Could Halve Treatment Times for Hepatitis C Study results are positive.
American Family Physician April 15, 2006 Karl E. Miller	Diagnosis and Treatment of Chlamydia trachomatis Infection Chlamydia trachomatis infection most commonly affects the urogenital tract. In men, the infection usually is symptomatic, with dysuria and a discharge from the penis. Most women with chlamydial infection have minimal or no symptoms, but some develop pelvic inflammatory disease.
Chemistry World December 9, 2009 Sarah Houlton	New hep C breakthrough A drug being developed by Denmark's Santaris Pharma could provide a breakthrough in the treatment of hepatitis C, and positive results in a study on chimpanzees point to its potential to avoid drug resistance.
American Family Physician March 15, 2004	Hepatitis C What is hepatitis C? How is it spread?
Chemistry World November 25, 2008 James Urquhart	Virus revealed by flipping lipid A drug that flags up virus-infected cells for destruction by the body's own immune system could lead to new, broad-spectrum anti-viral treatments, say US scientists.
The Motley Fool September 7, 2010 Luke Timmerman	Vertex Nails Third Big Trial With Hepatitis C Drug And in the toughest patients to treat, too.
American Family Physician September 1, 2006	Cirrhosis and Chronic Liver Failure: What You Should Know The basics about cirrhosis and chronic liver failure.
The Motley Fool July 27, 2011 Alexander Crawford	Vertex Moving Closer to a Cure for Hepatitis C How do you think the treatment of hepatitis C will evolve?
AskMen.com Dustin Driver	Travel Diseases: Central & South America There are more than a few diseases that can turn your dream vacation to Central or South America into a nightmare -- so here are a few "ounces of prevention."
Chemistry World February 14, 2011 Catherine Bacon	New hepatitis C drug Scientists in the UK have developed a compound to combat the hepatitis C virus that could be taken as a pill.
Chemistry World October 31, 2008 Matt Wilkinson	GSK Snaps up Hepatitis Drug Developer In a bid to strengthen its efforts to develop new hepatitis therapies, GSK has agreed to buy Genelabs Technologies in a deal worth $57 million.
AskMen.com Dustin Driver	Most Contagious Diseases Super-contagious diseases spread like wildfire. The best way to battle any of these nasty bugs is to avoid them altogether. Keep your eyes open for these most-unwanted diseases, and stay healthy.
The Motley Fool December 4, 2006 Brian Lawler	Success for Dynavax Solid results from the first of three phase III trials cause the biopharmaceutical Dynavax's shares to rise.
American Family Physician June 15, 2006	Hepatitis A: What You Should Know A patient guide: What is hepatitis A?... How is the disease spread?... How can I tell if I have the disease?... How is this disease treated?... How long will I be contagious?... etc.
The Motley Fool August 11, 2010 Brian Orelli	Dang! This Drug Is Shining Brighter Vertex illuminates telaprevir's additional benefit in treating hepatitis C patients.
The Motley Fool May 17, 2011 Luke Timmerman	Merck, Genentech Team Up on Hepatitis C Drug Merck pulling lots of strings to grab market share against Vertex.
The Motley Fool October 31, 2011 Brian Orelli	Gunning for the Leaders Hepatitis C drugs take center stage.
Chemistry World April 21, 2010 Sarah Houlton	Fresh hep C hope A new kind of compound to treat hepatitis C is showing promise in early clinical trials.
Chemistry World January 11, 2012 Andrew Turley	BMS spends $2.5 billion on antiviral firm The move will stock Bristol-Myers Squibb's pipeline with antivirals, most notably INX-189, a nucleotide polymerase inhibitor which is in Phase II trials for treating hepatitis C virus infection.
The Motley Fool March 31, 2011 Brian Orelli	Hepatitis C Drugs Heat Up The current hepatitis C drugs stink. Who's ahead in the race to find new ones?
American Family Physician June 15, 2003 Kathy Soch	Diary from a Week in Practice On individualizing treatment goals... Calming parent anxiety over child immunization... etc.
Chemistry World September 16, 2008 Hepeng Jia	Research Initiative Targets China's Major Killer Diseases A new epidemics research initiative is targeting China's biggest killer diseases: HIV/AIDS, tuberculosis (TB) and virulent hepatitis.
Pharmaceutical Executive June 1, 2014 Jill Wechsler	What Price Innovation? Payers, drug plans seek clear assessment of drug value to rationalize high drug prices.